DAVID SEFTEL, MD, MBA (CO-FOUNDER AND CEO)
David is a seasoned clinician with a strong background in biotech and entrepreneurship. At Harvard Business School, he co-founded the Health Industry Club which continues today to drive interdisciplinary innovation in the US and around the world. He has worked in a number of small startups, including helping to successfully pilot a diagnostic product through 510k certification. He has also advised and mentored numerous startups including those in the UCSF Lean Launchpad program and those presenting plans to venture capital and angel investors.
PETER ROBINSON, PHD (CO-FOUNDER AND CSO)
Peter is an inventor of the core ADAP technology and recently completed his doctorate in chemistry for graduate work performed at UC Berkeley and Stanford. In the course of his degree program, he initiated four projects that apply chemical principles to create tools for the detection glycoproteins and antibodies. These projects have demanded broad expertise in numerous techniques in chemical synthesis, bioconjugation, molecular biology, and immunology. This work forms the basis of several peer-reviewed papers and patents.
CAROLYN BERTOZZI, PHD (CO-FOUNDER AND CHAIR, SAB)
Carolyn is a Professor of Chemistry at Stanford and an Investigator with the Howard Hughes Medical Institute. She has been recognized with many honors and awards for her research accomplishments. She is an elected member of the Institute of Medicine, the National Academy of Sciences, and American Academy of Arts and Sciences. She has been awarded the Lemelson-MIT Prize, the Heinrich Wieland Prize, and a MacArthur Foundation Fellowship, among many others. In addition to her academic position, Carolyn recently guided the creation and acquisition of a biotech startup, Redwood Biosciences.
JASON TSAI (CO-FOUNDER AND CTO )
Jason is an inventor of the core ADAP technology and has extensive knowledge of immunology, protein biochemistry and engineering, and physical chemistry. As a graduate student at UC Berkeley and Stanford, he has filed numerous patents in biomedical science and published several peer-reviewed papers in cancer physical biology, diagnostics, and PCR-based assays. In addition, he was a graduate of the UCSF Lean Launchpad program, an NSF-sponsored biotechnology accelerator program. He was a Gold medalist at the 2004 International Chemistry Olympiad.
JESSE CORTEZ, PHD (SENIOR SCIENTIST)
Jesse is a Senior Scientist for Enable Biosciences with a PhD in synthetic organic chemistry from UC Berkeley. His synthetic experience led him to his post-doctoral work at UCSF where he synthesized antagonists for nuclear hormone receptors giving him experience in biochemistry, mass spectrometry and protein binding. At Enable Biosciences, he uses his broad scientific background to work on various new challenges that emerge, such as assay automation. When not working in the lab, he can be found performing musical theater around the Bay Area
DAVID GEHART (Assay Development Engineer)
David is an experienced researcher and engineer with a background in quality, manufacturing, and data management. His broad background has included roles at start-up and established companies; developing technologies, improving documentation, and optimizing processes for increased scale. David earned his bachelor’s degree from Olin College of Engineering which focuses on interdisciplinary engineering and project based learning.
Kenneth Danh (Research Associate)
Kenneth joins the lab in Spring 2018 as a research associate. He received a bachelor's degree from the department of biology at UC San Diego. His background experience includes the coordinating and conducting of experiments in clinical and preclinical research, maintaining regulatory compliance, and general lab management.